News
Ampio cleared to complete Phase 3 study for osteoarthritis Dec. 29, 2020 9:51 AM ET Ampio Pharmaceuticals, Inc. (AMPE) Stock AMPE By: Dulan Lokuwithana , SA News Editor 2 Comments ...
There is still risk present in the final Phase 3 expansion for OAK, but if investors agree to a likely approval and Ampion continues as expected the author projects Ampio Pharmaceuticals, Inc. to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback